Literature DB >> 24596373

Surgery for breast cancer liver metastases - factors determining results.

Vladislav Treska1, Monika Cerna, Vaclav Liska, Inka Treskova, Andrea Narsanska, Jan Bruha.   

Abstract

BACKGROUND/AIM: The results of the surgical treatment of liver metastases from breast cancer (BCLMs) may be determined by various factors. The aim of the present study was to specify the risk factors for surgical treatment of BCLM. PATIENTS AND METHODS: Twenty-four female patients with BCLMs were treated with liver resection or radiofrequency ablation (RFA). We evaluated the effects of patient age, time interval between the breast cancer and BCLM surgery, the type of surgical procedure, histopathological findings of the primary tumor, the number and overall diameter of BCLMs, the presence of resectable extra-hepatic metastases, and local tumor recurrence after breast cancer surgery on patients' overall (OS) and progression-free survival (PFS).
RESULTS: Age <50 years and shorter interval between breast and liver surgery were risk factors for poorer OS (p<0.02 and p<0.01, respectively) and for PFS (p<0.01 and p<0.01, respectively). The presence of extra-hepatic metastases was a risk factor for OS (p<0.005). An overall diameter of BCLM ≥3.5 cm and a negative status of both estrogen (ER) and progesterone receptors (PR) in the primary tumor were risk factors for poorer PFS (p<0.009 and p<0.0003, respectively).
CONCLUSION: The risk factors for surgery for BCLMs are age <50 years, the presence of extra-hepatic metastases, hormone receptor negativity of the primary tumor and an overall BCLM diameter ≥3.5 cm.

Entities:  

Keywords:  Breast cancer; extrahepatic metastases; liver metastases; surgery

Mesh:

Year:  2014        PMID: 24596373

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Resection of liver metastases from breast cancer: a multicentre analysis.

Authors:  X He; Q Zhang; Y Feng; Z Li; Q Pan; Y Zhao; W Zhu; N Zhang; J Zhou; L Wang; M Wang; Z Liu; H Zhu; Z Shao; L Wang
Journal:  Clin Transl Oncol       Date:  2019-06-22       Impact factor: 3.405

2.  Prognostic Factors After Surgical Treatment of Liver Metastases from Breast Cancer - 19 Years of Experience.

Authors:  KristÝna ProchÁzkovÁ; KristÝna PivovarČÍkovÁ; Milena RouŠarovÁ; Josef VodiČka; Petr HoŠek; Inka TŘeŠkovÁ; OndŘej Hes; Radek KuČera; OndŘej TopolČan; Vladislav TŘeŠka
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts.

Authors:  Mohammad A Alzubi; Sahib S Sohal; Madhumitha Sriram; Tia H Turner; Patricija Zot; Michael Idowu; J Chuck Harrell
Journal:  Clin Exp Metastasis       Date:  2019-05-08       Impact factor: 5.150

Review 4.  Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases.

Authors:  Gian Luca Grazi
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

5.  Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review.

Authors:  Kevin Rivera; Dhiresh Rohan Jeyarajah; Kimberly Washington
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

Review 6.  Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis.

Authors:  Federica Galiandro; Salvatore Agnes; Giovanni Moschetta; Armando Orlandi; George Clarke; Emilio Bria; Gianluca Franceschini; Giorgio Treglia; Francesco Giovinazzo
Journal:  Cancers (Basel)       Date:  2022-03-26       Impact factor: 6.639

7.  Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis.

Authors:  Yi-Bin Xiao; Bo Zhang; Yu-Lian Wu
Journal:  J Zhejiang Univ Sci B       Date:  2018-11       Impact factor: 3.066

Review 8.  Surgical therapy for breast cancer liver metastases.

Authors:  Kaori Terata; Kazuhiro Imai; Akiyuki Wakita; Yusuke Sato; Satoru Motoyama; Yoshihiro Minamiya
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

9.  A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study.

Authors:  Yu Xiong; Xia Shi; Qi Hu; Xingwei Wu; Enwu Long; Yuan Bian
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.